Pharmacology & ToxicologyMolecular Cancer TherapeuticsPeer-reviewed
Pharmacological Characterization of SDX-7320/Evexomostat: a Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-Tumor and Anti-Metastatic Activity
Peter Klaus Cornelius, Benjamin A. Mayes, John S. Petersen…·Bradley J. Carver
This paper characterizes SDX-7320, a MetAP2 inhibitor, showing reduced CNS toxicity and improved pharmacokinetics compared to previous fumagillin derivatives.
6 citations